Latest filing published 13 Aug 2025 for Xvivo Perfusion Aktiebolag, €21k.
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Gösta Johannesson (board member) discloses dealings in Xvivo Perfusion Aktiebolag to Finansinspektionen. The record holds 9 filings, for trades running from 11 February 2019 to 13 August 2025.
On the market, this insider has only ever bought: 9 purchases, €152k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2025, the count stands at 3 purchases and no sales.
Half of the purchases are above €15k and half below. Relative to company size, the median is 0.0026% of market cap (3 purchases with a known value). On 1 out of 9 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
The record was last updated on 13 August 2025 with an open-market purchase (€21k) in Xvivo Perfusion Aktiebolag. The median gap between trade and publication is zero days: most filings appear on the same day. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations